APA (7th ed.) Citation

Giesel, F. L., Flechsig, P., Kuder, T., Schwartz, L., Wulfert, S., Zechmann, C., . . . Kratochwil, C. (2013). Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177lu/90y-dotatoc and 213bi-dotatoc radiopeptide therapy.

Chicago Style (17th ed.) Citation

Giesel, F. L., P. Flechsig, T. Kuder, L. Schwartz, S. Wulfert, C. Zechmann, F. Bruchertseifer, U. Haberkorn, and C. Kratochwil. Contrast-enhanced Ultrasound Monitoring of Perfusion Changes in Hepatic Neuroendocrine Metastases After Systemic Versus Selective Arterial 177lu/90y-dotatoc and 213bi-dotatoc Radiopeptide Therapy. 2013.

MLA (8th ed.) Citation

Giesel, F. L., et al. Contrast-enhanced Ultrasound Monitoring of Perfusion Changes in Hepatic Neuroendocrine Metastases After Systemic Versus Selective Arterial 177lu/90y-dotatoc and 213bi-dotatoc Radiopeptide Therapy. 2013.